Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
Clinical trial NCT01590199 · COMPLETED
Trial details
- NCT number
- NCT01590199
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-18
- Primary completion
- 2018-09-11
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.